Ruxience (rituximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is a CD20-directed cytolytic antibody used for a variety of lymphomas leukemias and inflammatory conditions. Although Ruxience may be used to treat cancer it is not chemotherapy.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
Biologics (CD20 cytolytic antibodies)
WHAT IT TREATS:
Varies widely depending on the condition being treated
Length of infusion:
Varies depending on the condition being treated
FOR MORE INFORMATION: